Antiplatelet therapy after complex percutaneous coronary intervention and in left main coronary disease. Not all lesions are the same
Rev Esp Cardiol (Engl Ed). 2023 Apr;76(4):223-226.
doi: 10.1016/j.rec.2023.01.001.
Epub 2023 Jan 6.
[Article in
English,
Spanish]
Affiliation
- 1 Unidad de Hemodinámica, Servicio de Cardiología, Hospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain; Departamento de Medicina Clínica, Universidad Miguel Hernández, Alicante, Spain. Electronic address: ruiz_jmi@gva.es.
No abstract available
MeSH terms
-
Aspirin
-
Coronary Artery Disease* / therapy
-
Drug Therapy, Combination
-
Humans
-
Percutaneous Coronary Intervention*
-
Platelet Aggregation Inhibitors / therapeutic use
-
Treatment Outcome
Substances
-
Platelet Aggregation Inhibitors
-
Aspirin